Skip to main content

Table 1 Baseline characteristics of the study population

From: RNA-expression of adrenomedullin is increased in patients with severe COVID-19

  COVID-19 Controls  
n 21 19  
Sex male 57.1% 57.9% p = n.s.*
Agea 50 ± 16 56 ± 20 p = n.s.#
ICU admission 28.6% 5.3% p = n.s.*
Death 19.0% 5.3% p = n.s.*
Coronary artery disease 4.8% 36.8% p = 0.02*
Chronic heart failure 4.8% 15.8% p = n.s.*
Chronic obstructive pulmonary disease 0.0% 21.1% p = 0.04*
Hypertension 28.6% 47.4% p = n.s.*
Hyperlipidemia 9.5% 36.8% p = n.s.*
Diabetes 4.8% 26.3% p = n.s.*
Chronic renal failure 9.5% 21.1% p = n.s.*
Heart frequency [bpm]a 96 ± 15 92 ± 27 p = n.s.#
Systolic blood pressure [mmHg]a 132 ± 20 134 ± 28 p = n.s.#
Oxygen saturationa 95 ± 4% 95 ± 3% p = n.s.#
Respiratory rate [per minute]a 22 ± 7 21 ± 7 p = n.s.#
Temperature [°C]a 37.7 ± 0.7 37.4 ± 0.9 p = n.s.#
BMIa 27.8 ± 5.6 27.6 ± 5.3 p = n.s.#
NEWS-2 Scoreb 4 ± 5 3 ± 4 p = n.s.#
Creatinine [mg/dl]b 0.88 ± 0.58 0.95 ± 0.55 p = n.s.#
CRP [mg/l]b 43.4 ± 66.7 48.4 ± 74.0 p = n.s.#
WBC [/nl]b 7.2 ± 4.7 8.1 ± 7.9 p = n.s.#
IL-6 [pg/ml]b 30.7 ± 50.1 35.8 ± 87.5 p = n.s.#
ADM/GAPDH expressiona 0.88 ± 0.45 0.58 ± 0.35 p = 0.025
  1. *Tested with Fisher’s exact test
  2. #Tested with Mann-Whitney U test
  3. aValues are mean ± standard deviation
  4. bValues are median ± interquartile range